Yu Yong sold $1K of GNLX

Yu Yong (Chief Scientific Officer) sold 668 shares of GENELUX Corp (GNLX) at $2.01 on 2026-11-03.

Original reporting
SEC EDGAR · Yu Yong
Published Nov 5, 2026, 10:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 10:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GNLX
Neutral
high confidence
Mentioned
$GNLX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GNLXNeutralLow
01

Why it matters

The sale is unlikely to affect price materially; traders may monitor for larger insider activity or upcoming corporate events.

02

Market read

A routine insider sale with minimal market impact; low trading relevance.

03

What to watch

Potential upcoming clinical trial results or regulatory filings that may drive the stock more than the insider transaction.

Relevance 3/10Novelty 3/10Timing: same‑day filing

Background

Form 4 filings are primary disclosures of insider transactions. This filing reports a modest open‑market sale by the company's CSO.

Company-level read

Ticker impact

$GNLXNeutralHigh confidence
Context

Chief Scientific Officer Yu Yong sold 668 shares for $1,343.55, reducing his stake to 258,020 shares.

Expected impact

slight downward pressure as the market prices the modest sell‑off

Evidence & confidence

The transaction size is tiny relative to float and market cap; no 10b5‑1 plan indicates a discretionary sale, but the amount is not material.

Market effects

None; the sale does not affect the biotech sector broadly.

None; the company is US‑listed and the trade is too small to influence regional markets.

None

Counterpoint

If the insider is offloading shares due to upcoming negative news, the sale could foreshadow a larger move.

Key entities

  • GENELUX Corp

    Biotech firm listed on US exchanges under ticker GNLX.

  • Yu Yong

    Chief Scientific Officer of GENELUX Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles